TGFBeta Antibodies, Methods and Uses
AssigneeScholar Rock, Inc.
InventorsGregory J. Carven, Thomas Schurpf, Katherine Turner
Life of this patent
Estimating the term…
Abstract
ProTGFβ1-GARP complex-selective antibodies, polynucleotides capable of encoding the proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments, cells expressing proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments, as well as associated vectors and detectably labeled proTGFβ1-GARP complex-selective antibodies or antigen-binding fragments may be used to enhance an immune response in a subject, for example, against a cancer.
Claims21
An isolated antibody, or an antigen-binding fragment thereof, wherein the antibody or antigen binding fragment specifically binds to human proTGFβ1 in a complex with human glycoprotein A repetitions predominant (proTGFβ1-GARP complex) while said complex is in solution and the antibody or antigen binding fragment thereof has no detectable binding according to the biolayer interferometry assay using the experimental design described in Example 4 to any of the following agents:
- a TGFβ1 growth factor domain,
- a TGFβ2 growth factor domain,
- a TGFβ3 growth factor domain,
- proTGFβ1 covalently associated with LTBP1,
- proTGFβ1 covalently associated with LTBP3,
- proTGFβ1 covalently associated with LRRC33, and
- proTGFβ1 that is unassociated with human GARP,
- a. as measured by OctetRed 384 under the conditions shown in Examples 4 and 6 and further wherein the antibody or antigen-binding fragment thereof has an inhibitory concentration (IC50) of less than or equal to 10 nM for inhibition of TGFβ1 growth factor release from a cell-associated proTGFβ1-GARP complex under the conditions shown in Example wherein the antibody or antigen binding fragment comprises:
- b. a heavy chain CDR1 having the amino acid sequence of SEQ ID NO:
- 4, a heavy chain CDR2 having the amino acid sequence of SEQ ID NO:
- 5, and a heavy chain CDR3 having the amino acid sequence of SEQ ID NO:
- 6, a light chain CDR1 having the amino acid sequence of SEQ ID NO:
- 7, a light chain CDR2 having the amino acid sequence of SEQ ID NO:
- 8, and a light chain CDR3 having the amino acid sequence of SEQ ID NO:
- 9;
- or
- c. a heavy chain CDR1 having the amino acid sequence of SEQ ID NO:
- 10, a heavy chain CDR2 having the amino acid sequence of SEQ ID NO:
- 11, and a heavy chain CDR3 having the amino acid sequence of SEQ ID NO:
- 12, a light chain CDR1 having the amino acid sequence of SEQ ID NO:
- 13, a light chain CDR2 having the amino acid sequence of SEQ ID NO:
- 14, and a light chain CDR3 having the amino acid sequence of SEQ ID NO:
- 15.
An isolated antibody, or an antigen-binding fragment thereof, comprising a heavy chain variable region selected from the group consisting of the amino acid sequences of SEQ ID NOs:
- 16 and 18 and a light chain variable region selected from the group consisting of the amino acid sequences of SEQ ID NOs:
- 17 and 19.
The antibody or antigen-binding fragment of claim 9, wherein
- a. the heavy chain variable region comprises the amino acid sequence of SEQ ID NO:
- 16 paired with a light chain variable region comprising the amino acid sequence of SEQ ID NO:
- 17;
- or
- b. the heavy chain variable region comprises the amino acid sequence of SEQ ID NO:
- 18 paired with a light chain variable region comprising the amino acid sequence of SEQ ID NO:
- 19.
The antigen-binding fragment of claim 11 wherein the antigen binding fragment is a Fab fragment, a Fab2 fragment, or a single chain antibody.
The antibody or antigen-binding fragment of claim 11 wherein the antibody or antigen-binding fragment is recombinant.
The antibody or antigen-binding fragment of claim 13 wherein the antibody or antigen-binding fragment thereof are of IgG1, IgG2, IgG3, or IgG4 isotype.
The antibody or antigen-binding fragment of claim 14, wherein the antibody is an IgG4 isotype.
An isolated antibody, or an antigen-binding fragment thereof, comprising:
- a. a heavy chain CDR1 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 4, a heavy chain CDR2 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 5, and a heavy chain CDR3 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 6, a light chain CDR1 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 7, a light chain CDR2 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 8, and a light chain CDR3 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 9;
- or
- b. a heavy chain CDR1 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 10, a heavy chain CDR2 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 11, and a heavy chain CDR3 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 12, a light chain CDR1 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 13, a light chain CDR2 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 14, and a light chain CDR3 having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 15.
An isolated antibody, or an antigen-binding fragment thereof, comprising:
- a. a heavy chain variable region having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 16 paired with a light chain variable region having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 17;
- or
- b. a heavy chain variable region having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 18 paired with a light chain variable region having at least 80% identity to the amino acid sequence of SEQ ID NO:
- 19.
A vector comprising the polynucleotide of claim 18.
A host cell comprising the vector of claim 19.
A process for the production of an antibody or antigen-binding fragment, comprising:
- culturing the host cell as defined in claim 20 under the conditions allowing the expression of the antibody or antigen-binding fragment, and recovering the antibody or antigen-binding molecule from the culture.
Dependencies are inferred from the claim text.